DCF — LOVELACE WOMENS HOSPITAL
Enterprise Value: $123.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$123.6M
Enterprise Value
$31.3M
PV of Cash Flows
$92.3M
PV of Terminal Value
$148.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $204.8M | $17.1M | 8.0% | $5.4M | $4.9M |
| Year 2 | $210.9M | $19.7M | 9.0% | $7.2M | $5.9M |
| Year 3 | $217.2M | $22.5M | 10.0% | $9.0M | $6.8M |
| Year 4 | $223.8M | $24.3M | 11.0% | $10.1M | $6.9M |
| Year 5 | $230.5M | $25.6M | 11.0% | $10.9M | $6.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $123.6M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$198.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.07851300697725401
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5